Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

SVRA | Savara Inc

IndexRUT P/E- EPS (ttm)-0.28 Insider Own37.52% Shs Outstand114.05M Perf Week0.00%
Market Cap510.94M Forward P/E- EPS next Y-0.29 Insider Trans7.28% Shs Float84.45M Perf Month0.80%
Income-42.69M PEG- EPS next Q-0.07 Inst Own34.77% Short Float / Ratio3.49% / 5.55 Perf Quarter18.31%
Sales0.00M P/S- EPS this Y-15.20% Inst Trans2.93% Short Interest2.95M Perf Half Y85.29%
Book/sh0.77 P/B4.92 EPS next Y-0.69% ROA-30.86% Target Price4.60 Perf Year147.06%
Cash/sh0.78 P/C4.86 EPS next 5Y- ROE-39.75% 52W Range1.08 - 4.21 Perf YTD143.87%
Dividend- P/FCF- EPS past 5Y32.33% ROI-37.47% 52W High-10.21% Beta0.87
Dividend %- Quick Ratio18.33 Sales past 5Y-20.00% Gross Margin- 52W Low250.00% ATR0.15
Employees28 Current Ratio18.33 Sales Q/Q- Oper. Margin0.00% RSI (14)53.56 Volatility3.42% 4.06%
OptionableYes Debt/Eq0.30 EPS Q/Q-24.83% Profit Margin- Rel Volume0.62 Prev Close3.78
ShortableYes LT Debt/Eq0.30 EarningsAug 10 AMC Payout- Avg Volume531.11K Price3.78
Recom1.00 SMA200.84% SMA503.10% SMA20043.33% Volume328,300 Change0.00%
Date Action Analyst Rating Change Price Target Change
May-16-23Upgrade Jefferies Hold → Buy $2 → $4
Mar-31-23Downgrade Jefferies Buy → Hold $2
Mar-16-21Initiated Piper Sandler Overweight $7
Mar-15-21Initiated Oppenheimer Outperform $4
Jun-13-19Reiterated H.C. Wainwright Buy $22 → $6
Jun-13-19Downgrade Ladenburg Thalmann Buy → Neutral $21 → $3
Jun-13-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-13-18Resumed ROTH Capital Neutral $12
Jan-03-18Initiated Ladenburg Thalmann Buy $35
Sep-27-17Resumed ROTH Capital Buy $40
Sep-11-17Initiated JMP Securities Mkt Outperform $20
Sep-17-23 10:54AM
Sep-12-23 09:12AM
Sep-05-23 04:05PM
Aug-10-23 04:05PM
Aug-04-23 04:05PM
07:00AM Loading…
Jul-13-23 07:00AM
Jun-26-23 04:05PM
Jun-02-23 08:05AM
May-28-23 08:26AM
May-16-23 12:32PM
May-15-23 08:05AM
May-05-23 04:05PM
Apr-03-23 07:33AM
Mar-31-23 04:05PM
04:05PM Loading…
Mar-30-23 04:05PM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 04:05PM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
04:05PM Loading…
Feb-28-23 04:05PM
Feb-27-23 06:50AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-14-23 08:05AM
Feb-13-23 07:30AM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Feb-08-23 06:45AM
Feb-07-23 06:46AM
Feb-06-23 06:56AM
Feb-03-23 06:32AM
Feb-02-23 06:43AM
Feb-01-23 06:14AM
Jan-31-23 06:50AM
Jan-30-23 06:42AM
Jan-27-23 03:47PM
Jan-26-23 06:44AM
Jan-25-23 06:39AM
Jan-24-23 06:48AM
Jan-23-23 06:58AM
Jan-20-23 08:05AM
Jan-19-23 06:43AM
Jan-18-23 06:28AM
Jan-17-23 06:27AM
Jan-13-23 06:56AM
Jan-12-23 06:50AM
Jan-11-23 06:53AM
Jan-09-23 06:31AM
Jan-06-23 06:49AM
Jan-05-23 05:43AM
Jan-04-23 06:54AM
Jan-03-23 06:26AM
Dec-30-22 07:17AM
Dec-29-22 06:51AM
Dec-27-22 07:11AM
Dec-23-22 06:32AM
Nov-22-22 04:05PM
Nov-10-22 04:05PM
Nov-09-22 04:05PM
Sep-14-22 04:05PM
Sep-06-22 04:05PM
Sep-03-22 08:16AM
Sep-01-22 08:05AM
Aug-26-22 08:05AM
Aug-25-22 08:05AM
Aug-11-22 04:05PM
Jul-28-22 01:43PM
Jul-11-22 08:05AM
Jul-08-22 07:10AM
Jun-17-22 09:40AM
Jun-16-22 08:05AM
Jun-13-22 12:33PM
Jun-01-22 04:05PM
May-23-22 09:55AM
May-17-22 04:05PM
May-11-22 04:05PM
May-05-22 09:00AM
Apr-29-22 11:16AM
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yang Rick10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:13 PM
SANDELL SCOTT D10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:11 PM
Walker Paul Edward10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:12 PM
Mathers Edward T10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:10 PM
Makhzoumi Mohamad10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:09 PM
Florence Anthony A. Jr.10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:08 PM
Chang Carmen10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:07 PM
Behbahani Ali10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:06 PM
BASKETT FOREST10% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:05 PM
Growth Equity Opportunities 1710% OwnerJul 17Buy3.00333,333999,99924,471,264Jul 19 07:04 PM
Pratt Raymond DennisChief Medical OfficerJun 26Buy2.936,50019,045160,000Jun 27 07:00 AM
RAMSAY DAVID ADirectorMay 26Buy2.6337,12497,5992,201,142May 26 11:31 AM
RAMSAY DAVID ADirectorMay 25Buy2.5712,87633,1302,164,018May 26 11:31 AM
RAMSAY DAVID ADirectorMay 24Buy2.5650,000127,8002,151,142May 26 11:31 AM
RAMSAY DAVID ADirectorDec 30Buy1.5529,00044,8342,101,142Jan 03 12:41 PM
RAMSAY DAVID ADirectorDec 29Buy1.547,00010,7522,072,142Jan 03 12:41 PM
RAMSAY DAVID ADirectorDec 28Buy1.503,2934,9232,065,142Dec 28 04:40 PM
RAMSAY DAVID ADirectorDec 23Buy1.4415,70722,6652,061,849Dec 28 04:40 PM
RAMSAY DAVID ADirectorDec 22Buy1.4841,41461,1272,046,142Dec 22 03:19 PM
Pratt Raymond DennisChief Medical OfficerDec 22Buy1.543,5005,402153,500Dec 22 03:22 PM
RAMSAY DAVID ADirectorDec 20Buy1.5013,83020,7592,001,142Dec 20 01:29 PM
RAMSAY DAVID ADirectorDec 20Buy1.483,5865,3072,004,728Dec 22 03:19 PM
RAMSAY DAVID ADirectorDec 19Buy1.4940,71960,8341,987,312Dec 20 01:29 PM
RAMSAY DAVID ADirectorDec 16Buy1.503415121,946,593Dec 20 01:29 PM
Elam Nevan CDirectorDec 13Option Exercise0.651,17276229,244Dec 15 04:07 PM
Hawkins Richard JDirectorDec 07Option Exercise0.651,1727621,900Dec 08 05:08 PM
RAMSAY DAVID ADirectorNov 23Buy1.444,6106,6341,946,252Nov 25 08:30 AM
RAMSAY DAVID ADirectorNov 22Buy1.4215,49522,0181,941,642Nov 25 08:30 AM
RAMSAY DAVID ADirectorNov 21Buy1.4225,00535,5321,926,147Nov 21 04:39 PM
RAMSAY DAVID ADirectorNov 18Buy1.3416,10021,6061,901,142Nov 21 04:39 PM
RAMSAY DAVID ADirectorNov 17Buy1.278,90011,3031,885,042Nov 21 04:39 PM